+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Detrol"

Global Overactive Bladder Treatment Market by Drug Therapy (Anticholinergic, BOTO, Darifenacin), Disease Type (Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity), Distribution - Forecast 2024-2030 - Product Thumbnail Image

Global Overactive Bladder Treatment Market by Drug Therapy (Anticholinergic, BOTO, Darifenacin), Disease Type (Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity), Distribution - Forecast 2024-2030

  • Report
  • March 2024
  • 194 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Detrol (tolterodine) is a medication used to treat overactive bladder, a condition characterized by urinary frequency, urgency, and incontinence. It is a muscarinic receptor antagonist, meaning it works by blocking the action of a certain type of neurotransmitter in the bladder. Detrol is available in both immediate-release and extended-release formulations. It is typically taken twice daily, with or without food. Detrol is one of several medications used to treat urological disorders. Other drugs used to treat overactive bladder include anticholinergics, beta-3 agonists, and alpha-blockers. These medications work in different ways to reduce symptoms of overactive bladder. Detrol is marketed by several pharmaceutical companies, including Pfizer, Astellas Pharma, and Mylan. It is available in generic form from several generic manufacturers, including Teva Pharmaceuticals, Sandoz, and Actavis. Show Less Read more